COMPETITIVE TECHNOLOGIES ANNOUNCES SALES ORDER FROM ELS FOR PAIN MANAGEMENT DEVICES
Competitive Technologies Announces Sales Order From ELS for Pain Management Devices
Fairfield, CT – (January 12, 2009) – Competitive Technologies, Inc. (NYSE Alternext US: CTT) voiced currently which it has perceived a sales sequence from Excel Life Sciences, Inc. (ELS) for pang government caring devices. The device is a non-invasive routine for fast diagnosis of high-intensity oncologic as well as neuropathic pain, together with pang resistant to hypnotic as well as alternative drugs. ELS, CTT’s country-exclusive distributor in India, noticing a benefits of a innovative device, was a initial voiced healthcare services provider to pointer a placement agreement for a device. Subsequent placement agreements postulated country-exclusive placement rights to GEOMC Co., Ltd. for Korea, to AG Healthcare for Malaysia, as well as to Biogene Pharma Limited for Bangladesh.
The sequence from ELS has an estimate sell worth of up to million. Shipment of a inclination to ELS is scheduled to proceed immediately.
ELS is a U.S.-based, India-focused provider of clinical investigate as well as healthcare services. They have a special concentration upon mending studious caring in a markets in which they operate. ELS has a fully-owned Indian auxiliary with a categorical bureau in New Delhi, as well as twenty-one operational locations portion a network of over 700 hospitals opposite India.
The CTT device has Medical Device CE acceptance from a European Union permitting sales of a device via Europe as well as multiform alternative countries, together with India. Approval of CTT’s tentative FDA 510(k) healing device focus will sanction U.S. sales of a device. The examination as well as preference routine for distributors in Europe, Asia, a U.S. as well as Latin America is continuing. CTT has disdainful worldwide rights to this law device.
Dr. Vijai Kumar, ELS’s President as well as Chief Medical Officer, said, “We have seen this device in action, as well as have witnessed a pang relieving capabilities. ELS is starting grave clinical studies regulating this brand brand brand new pang government device during 4 heading healthcare comforts in India inside of a month. The custom for these studies will follow U.S. FDA discipline as well as provide a sum of 160 patients widely separated in to 4 specific neuropathies. We design this brand brand brand new device to beginner a model shift in a notice as well as diagnosis of pang in India. There have been over 4 million people in a nation pang from serious cancer, neuropathic pang as well as alternative forms of ongoing disabling pain.”
Mohit Mehrotra, ELS’s Founder as well as Chief Operating Officer, commented, “We have been unapproachable to work with CTT to move this on-going healing record to India. We have been focusing substantial resources upon this record as well as a attribute with CTT. We will be rising a device during a All India Institute of Medical Sciences’ (AIIMS) International Conference of Indian Association of Palliative Care in February, where you design it to beget a tall turn of wake up as well as seductiveness between a participants. ELS is a unite of a New Delhi-based conference, a largest of a type. Our endless hold about healthcare in India, along with a vast network of investigate hospitals as well as clinics, helps us assimilate a needs as well as expectations of both patients as well as healthcare providers. We hold this device will shift pang government for both constituents.”
“ELS is a pass component in a plan for office building a clever placement bottom opposite a Indian continent by Southeast Asia,” pronounced Aris D. Despo, CTT’s Executive VP, Business Development. “They have been an in effect as well as vital partner for CTT in a critical Indian market. India’s .75 billion healing device market, upheld by a flourishing center as well as top classes of over 150 million people, represents a poignant event for sales of a innovative pang government technology.”
“We hold which income as well as enlarge from a pang government record will dramatically surpass those constructed by any alternative record in a 40-year story as well as strech we estimate 0 million per year in distributor sales to hospitals as well as clinics as a device attains grown up marketplace levels,” pronounced John B. Nano, CTT’s Chairman, President as well as CEO. “We design monetary formula generated by this healing device to have a intensity to significantly enlarge CTT marketplace capitalization. This healing device is a budding e.g. of a plan to bond clinical scholarship to studious care, mending healthcare for mankind.”
Developed in Italy by CTT’s client, Prof. Giuseppe Marineo, a record was brought to CTT by a efforts of Prof. Giancarlo Elia Valori of a Italian commercial operation growth group, Sviluppo Lazio S.p.A., as well as good from a Zangani Investor Community™. The technology, with a biophysical rsther than than a biochemical approach, uses a multi-processor means to concurrently provide mixed pang areas by requesting aspect electrodes to a skin. CTT partner, GEOMC Co., Ltd. of Korea, is production a device commercially for worldwide distribution. For some-more report upon a device, revisit www.CalmareTT.com.
The device has been used upon over 3,000 patients in Europe, together with during a Pain Management Center during Tor-Vergata University Medical Center in Rome (http://www.ptvonline.it/uo_ter_ant_ing.asp)., as well as during Fondazione Parco Biomedico San Raffaele in Rome (www.scienceparkrome.eu).
About Excel Life Sciences, Inc.
ELS is a U.S.-based, India-focused provider of extensive clinical investigate as well as healthcare services, assisting to allege scholarship as well as urge studious care. ELS is a secretly owned Delaware corporation, with twenty-one operational locations opposite India as well as a network of we estimate 1,000 physicians portion over 700 hospitals. ELS has U.S. offices in Boston, Chicago, as well as Durham, N.C. Its success is built around ardent as well as gifted people operative to one side clients to accelerate clinical investigate as well as broach brand brand brand new drug as well as healing inclination to a markets, whilst progressing a top standards of quality. ELS is committed to mending as well as expanding a clinical investigate craving in India. Visit ELS’s website: www.ExcelLifeSciences.com
About Competitive Technologies
Competitive Technologies, determined in 1968, is a full use record send as well as chartering provider focused upon a record needs of a business as well as transforming those mandate in to commercially viable solutions. CTT is a tellurian personality in identifying, building as well as commercializing innovative technologies in life, electronic, nano, as well as earthy sciences grown by universities, companies as well as inventors. CTT maximizes a worth of egghead resources for a good of a customers, clients as well as shareholders. Visit CTT’s website: www.competitivetech.net
Statements done about a destiny expectations have been forward-looking statements as well as theme to risks as well as uncertainties as described in a many new Annual Report upon Form 10-K for a year finished Jul 31, 2008, filed with a SEC upon Oct 28, 2008, as well as alternative filings with a SEC, as well as have been theme to shift during any time. Our tangible formula could talk about materially from these forward-looking statements. We commence no requisite to refurbish publicly any forward-looking statement.
Read Also
Tags: Announces, competitive, Devices, from, Management, Order, Pain, Sales, technologies